Sign Up
Stories
Celyad Oncology Expands Share Capital
Share
Advancements in Cancer Treatment and Mar...
Advancements in Gene Editing and Cancer ...
BioSenic's Progress and Patent
ANJESO Drug Insight and Market Forecast
Acquisition Progress Amid Safety Concern
Afya Limited Expands Medical Seats in Br...
Overview
API
Celyad Oncology, a biotechnology company, announces the issuance of new shares, increasing its share capital. The company focuses on developing CAR T-cell therapies and is based in Mont-Saint-Guibert, Belgium.
Ask a question
How might Celyad Oncology's expansion of share capital impact its research and development efforts?
How might the issuance of new shares affect Celyad Oncology's financial stability and future growth?
What are the potential implications of Celyad Oncology's focus on CAR T-cell therapies for the biotechnology industry?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Jun 2023
Jul 2023
Aug 2023
Coverage